CCAP Stock Analysis: Buy, Sell, or Hold?
CCAP - Crescent Capital BDC, Inc. Common stock
$14.39
0.04 (0.28%)
β²
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 18, 2026
17d
Get Alerted When CCAP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
π‘ BUY OPPORTUNITY: CCAP shows positive signals but monitor for confirmation. Market pricing in 0.2% decline. Moderate conviction.
π‘ BUY OPPORTUNITY: CCAP shows positive signals but monitor for confirmation. Market pricing in 0.2% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.09
Based on -3.5% avg growth
INTRINSIC VALUE TODAY
$7.51
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CCAP is currently trading at $14.39, which is considered fair relative to its 30-day fair value range of $14.27 to $14.64. The stock's valuation (Forward PE: 9.0) is in line with its historical norms (9.1). Remarkably, the market is currently pricing in an annual earnings decline of 0.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CCAP is showing sideways momentum. The price is currently testing key support at $14.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CCAP is showing sideways momentum. The price is currently testing key support at $14.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$14.27 -
$14.64
Company Quality Score
57/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
68.1%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($15.75)
Fair Price Analysis
30-Day Fair Range
$14.27 -
$14.64
Current vs Fair Value
FAIR
Expected Move (7 Days)
Β±$1.42
(9.9%)
Support & Resistance Levels
Support Level
$14.16
Resistance Level
$14.85
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
9.00
Wall Street Target
$15.75
(+9.8%)
Revenue Growth (YoY)
-19.9%
Earnings Growth (YoY)
-53.5%
Profit Margin
20.8%
Valuation Discount vs History
-0.2% cheaper
PE vs Historical
9.0 vs 9.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.2%
(market-implied from PE analysis)
1-Year Target
$14.32
(0%)
2-Year Target
$14.29
(0%)
3-Year Target
$14.26
(-1%)
3-Yr Target (if PE normalizes)
(PE: 9β9)
$14.43
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: -10.9%)
$25.93
(+81%)
Base:
(SPY PE: 9.0, Growth: -10.9%)
$10.46
(-27%)
Bear:
(PE: 7.6, Growth: -10.9%)
$8.89
(-38%)
π
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (15x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 14.62 | Current EPS (TTM): $0.97
Bull Case
$25.65
(+78%)
Analyst growth 64.4%, PE expands to 16.1
Base Case
$23.32
(+62%)
Market implied 64.4%, PE stable at 14.6
Bear Case
$9.64
(-33%)
Severe decline -20.0%, PE contracts to 12.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
π‘
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.0 to 9.1
Stabilization Target:
$14.51
(+1.1%)
PE Expansion Potential:
+1.1%
Last updated: January 30, 2026 10:52 PM ET
Data refreshes hourly during market hours. Next update: 11:52 PM
Data refreshes hourly during market hours. Next update: 11:52 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CCAP showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Kirill Bouek
BUY
200 shares
2025-08-28
Raymond Barrios
BUY
3245 shares
2025-08-25
Top Rated Asset Management Stocks
Top-rated stocks in Asset Management by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BLK
BlackRock Inc |
STRONG BUY
17 analysts |
$1334 | 59 HOLD |
|
HASI
Hannon Armstrong Sustain⦠|
STRONG BUY
16 analysts |
$40 | 63 BUY |
|
APO
Apollo Global Management⦠|
STRONG BUY
19 analysts |
$165 | 56 HOLD |
|
CRBG
Corebridge Financial Inc. |
STRONG BUY
14 analysts |
$38 | 66 BUY |
|
BX
Blackstone Group Inc |
HOLD
23 analysts |
$178 | 52 HOLD |
Advanced CCAP Option Strategies
Professional options setups generated by AI based on today's CCAP price and gamma walls.